227
Views
12
CrossRef citations to date
0
Altmetric
Review

Topical preservative-free ophthalmic treatments: an unmet clinical need

ORCID Icon, , , ORCID Icon, , & ORCID Icon show all
Pages 655-672 | Received 19 Jul 2020, Accepted 02 Dec 2020, Published online: 16 Dec 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Christina Scelfo, Reem H. ElSheikh, Muhammad M. Shamim, Javaneh Abbasian, Alireza Ghaffarieh & Abdelrahman M. Elhusseiny. (2023) Ocular Surface Disease in Glaucoma Patients. Current Eye Research 48:3, pages 219-230.
Read now
Francesco Oddone, Vincenzo Scorcia, Michele Iester, Dario Sisto, Stefano De Cilla, Paolo Bettin, Carlo Cagini, Michele Figus, Giorgio Marchini, Luca Rossetti, Gemma Rossi, Tommaso Salgarello, Gian Luca Scuderi & Giovanni Staurenghi. (2022) Treatment of Open-Angle Glaucoma and Ocular Hypertension with the Fixed-Dose Combination of Preservative-Free Tafluprost/Timolol: Clinical Outcomes from Ophthalmology Clinics in Italy. Clinical Ophthalmology 16, pages 1707-1719.
Read now
Gábor Holló, Andreas Katsanos, Konstadinos G. Boboridis, Murat Irkec & Anastasios G. Konstas. (2021) Letter to the editor: ‘topical preservative-free ophthalmic treatments an unmet clinical need’. Expert Opinion on Drug Delivery 18:4, pages 527-529.
Read now
Anastasios G. Konstas, Antoine Labbé, Andreas Katsanos, Frances Meier-Gibbons, Murat Irkec, Konstadinos G. Boboridis, Gábor Holló, Julián García-Feijoo, Gordon N. Dutton & Christophe Baudouin. (2021) The treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerability. Expert Opinion on Drug Safety 20:4, pages 453-466.
Read now

Articles from other publishers (8)

Anastasios-Georgios Konstas, Konstadinos G. Boboridis, Georgios P. Athanasopoulos, Anna-Bettina Haidich, Irini C. Voudouragkaki, Eirini Pagkalidou, Andreas Katsanos & L. Jay Katz. (2023) Changing from preserved, to preservative-free cyclosporine 0.1% enhanced triple glaucoma therapy: impact on ocular surface disease—a randomized controlled trial. Eye 37:17, pages 3666-3674.
Crossref
Michele Figus, Matteo Sacchi, Gemma Caterina Rossi, Silvia Babighian, José Manuel Benitez Del Castillo, Laura de Polo, Eugenio Melchionda & Chiara Posarelli. (2023) Ocular surface and glaucoma, a mutual relationship. Practical suggestions for classification and management. European Journal of Ophthalmology.
Crossref
Christoph Tappeiner, Arnd Heiligenhaus, Joerg P. Halter, Elisabetta Miserocchi, Francesco Bandello & David Goldblum. (2023) Challenges and concepts in the diagnosis and management of ocular graft-versus-host disease. Frontiers in Medicine 10.
Crossref
Nupur Vasdev, Nakshatra Chaudhari, Suryanarayana Polaka, Kuldeep Rajpoot, Piyush Gondaliya, Adil Ali Sayyed, Pinaki Sengupta & Rakesh Kumar Tekade. (2023) Current progress in preservative-free topical ophthalmic formulations. Journal of Drug Delivery Science and Technology 79, pages 103996.
Crossref
Kassahun Alula Akulo, Terin Adali, Mthabisi Talent George Moyo & Tulin Bodamyali. (2022) Intravitreal Injectable Hydrogels for Sustained Drug Delivery in Glaucoma Treatment and Therapy. Polymers 14:12, pages 2359.
Crossref
Marion Barrieu, Philip Chennell, Mouloud Yessaad, Yassine Bouattour, Mathieu Wasiak, Mireille Jouannet, Yoann Le Basle & Valérie Sautou. (2022) Physicochemical Stability of a Novel Tacrolimus Ophthalmic Formulation for the Treatment of Ophthalmic Inflammatory Diseases. Pharmaceutics 14:1, pages 118.
Crossref
Bharti Gupta, Varsha Mishra, Sankalp Gharat, Munira Momin & Abdelwahab Omri. (2021) Cellulosic Polymers for Enhancing Drug Bioavailability in Ocular Drug Delivery Systems. Pharmaceuticals 14:11, pages 1201.
Crossref
Francesco Sartini, Martina Menchini, Chiara Posarelli, Giamberto Casini & Michele Figus. (2021) In Vivo Efficacy of Contact Lens Drug-Delivery Systems in Glaucoma Management. A Systematic Review. Applied Sciences 11:2, pages 724.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.